Program Overview
This educational activity will feature content presented at the MS Paris 2017 7th Joint ECTRIMS-ACTRIMS Meeting in Paris, France. Four expert faculty will examine recent prognosis and diagnostic strategies of multiple sclerosis. An analysis of clinical trial data of current and emerging disease modifying therapies as presented at the Joint ACTRIMS-ECTRIMS meeting will be discussed. The faculty will also review how to implement recent scientific data to safely manage patients with multiple sclerosis for optimal outcomes. Upon completion of this activity, learners will gain a better understanding of recent clinical trial data for the treatment of multiple sclerosis, ultimately improving patient outcomes.
Target Audience
This activity has been designed to meet the educational needs of neurologists, and other healthcare professionals responsible for the diagnosis, treatment or management of patients with multiple sclerosis.
Educational Objectives
Upon completion of this activity, participants will be better able to do the following:
1. Identify recent prognosis and diagnostic strategies of multiple sclerosis.
2. Review clinical trial data of current and emerging disease modifying therapies as presented at the Joint ACTRIMS-ECTRIMS meeting.
3. Incorporate recent scientific data to safely manage patients with multiple sclerosis for optimal outcomes.
Faculty
Fred D. Lublin, MD (Chair)
Saunders Family Professor of Neurology
Director, Corinne Goldsmith Dickinson Center for MS
Icahn School of Medicine at Mount Sinai
New York, NY
–
–
Peter Calabresi, MD
Director, Division of Neuroimmunology
Professor of Neurology
The Johns Hopkins Hospital
Baltimore, MD
–
–
Stephen Krieger, MD
Assistant Professor of Neurology
Corinne Goldsmith Dickinson Center for MS
Director, Neurology Residency Program
Icahn School of Medicine at Mount Sinai
New York, NY
–
–
Michael Racke, MD
Professor of Neurology and Neuroscience
Wexler Medical Center at The Ohio State University Medical Center
Columbus, OH
